Synergy Pharmaceuticals, Inc. (SGYP) will report its next earnings on May 10 AMC. The company reported the earnings of $-0.16/Share in the last quarter where the estimated EPS by analysts was $-0.19/share. The difference between the expected and actual EPS was $0.03/share, which represents an Earnings surprise of 15.8%.
Many analysts are providing their Estimated Earnings analysis for Synergy Pharmaceuticals, Inc. and for the current quarter 6 analysts have projected that the stock could give an Average Earnings estimate of $-0.16/share. These analysts have also projected a Low Estimate of $-0.19/share and a High Estimate of $-0.12/share.
In case of Revenue Estimates, 5 analysts have provided their consensus Average Revenue Estimates for Synergy Pharmaceuticals, Inc. as 11.5 Million. According to these analysts, the Low Revenue Estimate for Synergy Pharmaceuticals, Inc. is 7.5 Million and the High Revenue Estimate is 19.14 Million. The company had Year Ago Sales of 98 Million.
Some buy side analysts are also providing their Analysis on Synergy Pharmaceuticals, Inc., where 3 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
The Relative Volume of the company is 1.43 and Average Volume (3 months) is 3.92 million.
The company shows its Return on Assets (ROA) value of -142.4%. While it’s Return on Investment (ROI) value is -201.1%.
While looking at the Stock’s Performance, Synergy Pharmaceuticals, Inc. currently shows a Weekly Performance of 15.72%, where Monthly Performance is 1.66%, Quarterly performance is -11.11%, 6 Months performance is -38.05% and yearly performance percentage is -57.51%. Year to Date performance value (YTD perf) value is -17.49%. The Stock currently has a Weekly Volatility of 14.87% and Monthly Volatility of 7.88%.